investordatabase.org

5AM Ventures

5amventures.com Direct investor

5AM Ventures is a life science venture capital firm founded in 2002. It invests in private therapeutic companies, primarily at Series A, and also has a public equity strategy for small and mid-cap biotech companies.

5AM Ventures is a venture capital firm headquartered in San Francisco, United States, founded in 2002. It invests directly in companies, from seed to growth, in biopharmaceuticals, drug delivery technologies and life science instruments.

“5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies”

5AM Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedGrowth
Headquarters
San Francisco, United States
Invests in
global
Sectors
biopharmaceuticals, drug delivery technologies, life science instruments
Founded
2002

Team, as 5AM Ventures publishes it

  • Kush M Parmar Managing Partner
  • Andy J. Schwab Managing Partner
  • Anna Yaeger Chief Investment Officer and Partner
  • Michael Calore Partner, Head of Investor Relations
  • John Kelly Partner, Chief Financial Officer & Chief Operating Officer
  • Deborah Palestrant Partner, Executive Chair, 4:59 Initiative
  • John D. Diekman Founding Partner
  • Scott M. Rocklage Founding Partner

Names and roles exactly as listed on 5amventures.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page 5AM Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1033 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under